Literature DB >> 33713599

Structural mechanism underlying ligand binding and activation of PPARγ.

Jinsai Shang1, Douglas J Kojetin2.   

Abstract

Ligands bind to an occluded orthosteric ligand-binding pocket within the nuclear receptor ligand-binding domain. Molecular simulations have revealed theoretical ligand entry/exit pathways to the orthosteric pocket; however, it remains unclear whether ligand binding proceeds through induced fit or conformational selection mechanisms. Here, using nuclear magnetic resonance spectroscopy, isothermal titration calorimetry, and surface plasmon resonance analysis, we provide evidence that structurally distinct agonists bind peroxisome proliferator-activated receptor γ (PPARγ) via a two-step induced fit mechanism involving an initial fast kinetic step followed by a slow conformational change. The agonist encounter complex binding pose is suggested in crystal structures where ligands bind to a surface pore suggested as a ligand entry site in molecular simulations. Our findings suggest an activation mechanism for PPARγ whereby agonist binding occurs through an initial encounter complex followed by a transition of the ligand into the final binding pose within the orthosteric pocket, inducing a transcriptionally active conformation.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NMR spectroscopy; conformational selection; encounter complex; induced fit; ligand binding mechanism; nuclear receptor

Mesh:

Substances:

Year:  2021        PMID: 33713599      PMCID: PMC8418994          DOI: 10.1016/j.str.2021.02.006

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.871


  67 in total

1.  Ligand-escape pathways from the ligand-binding domain of PPARgamma receptor as probed by molecular dynamics simulations.

Authors:  D Genest; N Garnier; A Arrault; C Marot; L Morin-Allory; M Genest
Journal:  Eur Biophys J       Date:  2007-10-11       Impact factor: 1.733

2.  Evolution of Nuclear Receptors and Ligand Signaling: Toward a Soft Key-Lock Model?

Authors:  Guillaume Holzer; Gabriel V Markov; Vincent Laudet
Journal:  Curr Top Dev Biol       Date:  2017-03-25       Impact factor: 4.897

Review 3.  Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics.

Authors:  Pengxiang Huang; Vikas Chandra; Fraydoon Rastinejad
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

4.  The Phenix software for automated determination of macromolecular structures.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Swati Jain; Gary J Kapral; Ralf W Grosse Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert D Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Methods       Date:  2011-07-29       Impact factor: 3.608

5.  HL005--a new selective PPARγ antagonist specifically inhibits the proliferation of MCF-7.

Authors:  Weiqiang Lu; Peng Che; Yanyan Zhang; Honglin Li; Shien Zou; Jin Zhu; Jing Deng; Xu Shen; Hualiang Jiang; Jian Li; Jin Huang
Journal:  J Steroid Biochem Mol Biol       Date:  2011-02-04       Impact factor: 4.292

6.  Dynamic allosteric communication pathway directing differential activation of the glucocorticoid receptor.

Authors:  C Köhler; G Carlström; A Gunnarsson; U Weininger; S Tångefjord; V Ullah; M Lepistö; U Karlsson; T Papavoine; K Edman; M Akke
Journal:  Sci Adv       Date:  2020-07-17       Impact factor: 14.136

7.  SR2067 Reveals a Unique Kinetic and Structural Signature for PPARγ Partial Agonism.

Authors:  Laura M van Marrewijk; Steven W Polyak; Marcel Hijnen; Dana Kuruvilla; Mi Ra Chang; Youseung Shin; Theodore M Kamenecka; Patrick R Griffin; John B Bruning
Journal:  ACS Chem Biol       Date:  2015-12-03       Impact factor: 5.100

8.  T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties.

Authors:  Yang Li; Zhulun Wang; Noboru Furukawa; Patrick Escaron; Jennifer Weiszmann; Gary Lee; Michelle Lindstrom; Jinsong Liu; Xiaohong Liu; Haoda Xu; Olga Plotnikova; Vidya Prasad; Nigel Walker; R Marc Learned; Jin-Long Chen
Journal:  J Biol Chem       Date:  2008-02-07       Impact factor: 5.157

9.  Partial agonists activate PPARgamma using a helix 12 independent mechanism.

Authors:  John B Bruning; Michael J Chalmers; Swati Prasad; Scott A Busby; Theodore M Kamenecka; Yuanjun He; Kendall W Nettles; Patrick R Griffin
Journal:  Structure       Date:  2007-10       Impact factor: 5.006

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  1 in total

1.  Two steps, one ligand: How PPARγ binds small-molecule agonists.

Authors:  James J Siclari; Kevin H Gardner
Journal:  Structure       Date:  2021-09-02       Impact factor: 5.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.